ACO Name and Location

Southcoast Accountable Care Organization, LLC
101 Page Street
New Bedford, MA 02740

ACO Primary Contact

Primary Contact Name	Wade Broughman
Primary Contact Phone Number	508-973-2908
Primary Contact Email Address	BroughmanW@southcoast.org

Organizational Information

ACO participants:

ACO Participants	ACO Participant in Joint Venture
Augusta Rosenthal	N
Dermatology Services Inc	N
Geriatric Internal Medicine Specialists, Llc	N
Independence Eye Associates PC	N
Michael J Crowe 3rd	N
Obstetrical Associates Inc	N
Patrick Mccarthy	N
Robert A. Carrellas, MD PC	N
Sleep Medicine Associates Inc	N
Southcoast Cardiology LLC	N
Southcoast Physicians Group, Inc.	N
Southcoast Womans Care Pc	N
Surgical & Cosmetic Dermatology Of Rhode Island, Llc.	N
Truessdale Obstetrics & Gynecology, PC	N
Wiegandt and Associates, PC	N

ACO governing body:

Member Last Name	Member First Name	Member Title/Position	Member’s Voting Power: expressed as a percentage or number	Membership Type	ACO Participant Legal Business Name/DBA, if applicable
Broughman	Wade	Treasurer/Voting Member	1	ACO Participant Representative	Southcoast Physician’s Group, Inc.
Clark	Renee	Chief Operating Officer	1	ACO Participant Representative	Southcoast Physician’s Group, Inc.
Correia	Carlos	MD/Voting Member	1	ACO Participant Representative	Southcoast Physician’s Group, Inc.
Gagnon	Patrick	MD/Secretary/ Voting Member	1	ACO Participant Representative	Southcoast Physician’s Group, Inc.
Hurteau	Brett	MD/Voting Member	1	ACO Participant Representative	Southcoast Physician’s Group, Inc.
Kasparian	Stephen	MD/Voting Member	1	ACO Participant Representative	Obstetrical Associates, Inc.
Kruger	Rayford	President/Voting Member	1	ACO Participant Representative	Southcoast Physician’s Group, Inc.
Laus	Ana	MD/Voting Member	1	ACO Participant Representative	Southcoast Physician’s Group, Inc.
Liggin	Marcia	Voting Member	1	Medicare Beneficiary Representative
McGowen	Robert	MD/Voting Member & Chair	1	ACO Participant Representative	Southcoast Physician’s Group, Inc.
Mello	Curtis	MD/Voting Member & Vice Chair	1	ACO Participant Representative	Sleep Medicine Associates Inc
Mulchandani-West	Anjali	Voting Member	1	ACO Participant Representative	Southcoast Physician’s Group, Inc
Patrick	Diane	MD/Voting Member	1	ACO Participant Representative	Southcoast Physician’s Group, Inc
Torres	Efrain	MD/Voting Member	1	ACO Participant Representative	Geriatric Internal Medicine Specialists, LLC
Buiocci	Patricia K.	Voting Member	1	ACO Participant Representative	Southcoast Visiting Nurse Association, Inc.

Key ACO clinical and administrative leadership:

Wade Broughman	ACO Executive
Brett Hurteau, DO	Medical Director
Kyle Yermalovich	Compliance Officer
Lauren Melby Nieder	Quality Assurance/Improvement Officer

Associated committees and committee leadership:

Committee Name	Committee Leader Name and Position
Utilization & Performance Improvement (UPIC)	Curtis Mello, MD, Co-chair Lauren Melby Nieder, Co-chair
Executive Committee	Wade Broughman, Member Lauren Melby Nieder, Member Robert McGowen, MD Chair
Finance, Contracting & Funds Flow	Carlos Correia, MD, Co-chair Wade Broughman, Co-chair
Network Management Committee	Kimberley Coon, Member Michael Doyle, Member Lauren Melby Nieder, Member

Types of ACO participants, or combinations of participants, that formed the ACO:

Partnerships or joint venture arrangements between hospitals and ACO professionals

Shared Savings and Losses

Amount of Shared Savings/Losses

Third Agreement Period:
- Performance Year 2021, $4,047,898
- Performance Year 2020, $5,710,468
- Performance Year 2019, $4,623,080

Second Agreement Period:
- Performance Year 2019, $4,623,080
- Performance Year 2018, $0
- Performance Year 2017, $0
- Performance Year 2016, $0
First Agreement Period:
- Performance Year 2015, $0
- Performance Year 2014, $0
- Performance Year 2013, $0

Shared Savings Distribution

Third Agreement Period
- Performance Year 2021
  - Proportion invested in infrastructure: 25%
  - Proportion invested in redesigned care processes/resources: 25%
  - Proportion of distribution to ACO participants: 50%
- Performance Year 2020
  - Proportion invested in infrastructure: 25%
  - Proportion invested in redesigned care processes/resources: 25%
  - Proportion of distribution to ACO participants: 50%
  - Performance Year 2020
- Performance Year 2019
  - Proportion invested in infrastructure: 25%
  - Proportion invested in redesigned care processes/resources: 25%
  - Proportion of distribution to ACO participants: 50%

Second Agreement Period
- Performance Year 2019
  - Proportion invested in infrastructure: 25%
  - Proportion invested in redesigned care processes/resources: 25%
  - Proportion of distribution to ACO participants: 50%
- Performance Year 2018
  - Proportion invested in infrastructure: N/A
  - Proportion invested in redesigned care processes/resources: N/A
  - Proportion of distribution to ACO participants: N/A
- Performance Year 2017
  - Proportion invested in infrastructure: N/A
  - Proportion invested in redesigned care processes/resources: N/A
  - Proportion of distribution to ACO participants: N/A
- Performance Year 2016
  - Proportion invested in infrastructure: N/A
  - Proportion invested in redesigned care processes/resources: N/A
  - Proportion of distribution to ACO participants: N/A

First Agreement Period
- Performance Year 2015
  - Proportion invested in infrastructure: N/A
  - Proportion invested in redesigned care processes/resources: N/A
  - Proportion of distribution to ACO participants: N/A
- Performance Year 2014
  - Proportion invested in infrastructure: N/A
  - Proportion invested in redesigned care processes/resources: N/A
  - Proportion of distribution to ACO participants: N/A
- Performance Year 2013
  - Proportion invested in infrastructure: N/A
  - Proportion invested in redesigned care processes/resources: N/A
  - Proportion of distribution to ACO participants: N/A

Quality Performance Results

2021 Quality Performance Results:

Quality performance results are based on CMS Web Interface.

Measure #	Measure Name	Rate	ACO Mean
001	Diabetes: Hemoglobin A1c (HbA1c) Poor Control²	10.89	12.46
134	Preventative Care and Screening: Screening for Depression and Follow-up Plan	66.14	74.38
236	Controlling High Blood Pressure	71.72	74.87
318	Falls: Screening for Future Fall Risk	92.89	87.03
110	Preventive Care and Screening: Influenza Immunization	85.32	80.52
226	Preventative Care and Screening: Tobacco Use: Screening and Cessation Intervention	89.47	80.97
113	Colorectal Cancer Screening	73.78	73.63
112	Breast Cancer Screening	81.75	75.11
438	Statin Therapy for the Prevention and Treatment of Cardiovascular Disease	82.35	84.24
321	CAHPS for MIPS³	N/A	N/A
479	Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Groups²	0.161	0.154
MCC1	All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions for ACOs (MCC)²	35.23	33.99

Please note, the Quality ID #: 370 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size.

For Previous Years’ Financial and Quality Performance Results, please visit data.cms.gov.